The landscape of dementia prognosis has developed drastically with the appearance of refined biomarkers, including amyloid PET scans, tau imaging, and blood-based mostly checks that may detect Alzheimer's pathology several years before indicators arise. While these technological improvements characterize remarkable progress in comprehension neurode